Erschienen in:
20.06.2016 | Genes and Disease
Association of PTPN22 1858C→T polymorphism, HLA-DRB1 shared epitope and autoantibodies with rheumatoid arthritis
verfasst von:
Hala M. Raslan, Hanaa R. Attia, Iman Salama, Mona Hamed Ibrahim, Eman Mahmoud Hassan, Mohamed S. El Hussieny, Manal M. El Menyawi, Khalda S. Amr
Erschienen in:
Rheumatology International
|
Ausgabe 8/2016
Einloggen, um Zugang zu erhalten
Abstract
To assess impact of PTPN22 1858C→T polymorphism, HLA shared epitope and autoantibodies on susceptibility and severity of rheumatoid arthritis (RA). A total of 150 RA patients and 150 controls were included in the study. Anti-cyclic citrullinated peptide (anti-CCP) and rheumatoid factor isotypes (IgG, IgM and IgA) were assayed by ELISA. PTPN22 1858C→T polymorphism was performed by RFLP analysis and HLA-DRB1 genotyping by PCR-SSP analysis. Single-view, anteroposterior radiographs of the hands and feet were obtained on all RA patients. The results showed association of PTPN22 1858 T allele with RA (OR = 2.3, 95 % CI 1.5–3.5) and bone erosion (OR = 2.9, 95 % CI 1.1–7.6). The associations increased with the combination of positive autoantibodies, HLA-DRB1 SE with PTPN22 1858 T allele carriage. The highest association was with the combination with anti-CCP antibodies (OR = 47.3, 95 % CI 10.9–204.4 for RA and OR = 69.4, 95 % CI 15.8–305.5 for erosion p < 0.001). Combination of PTPN22 1858 T allele carriage with negative RF isotypes or with absence HLA-DRB1 SE showed no significant association with RA. The presence of PTPN22 1858C→T polymorphism with HLA SE and autoantibodies increases risk of RA development and erosive disease.